TRAVEL TO GREECE – IMPORTANT INFORMATION
We wish to inform you of the updated information regarding the conditions that apply for entry into Greece in order to prevent the spread of the corona virus COVID-19 (Government Gazette 2661/18.06.2021). Entrance to Greece is allowed to citizens of the European Union (EU) and members of their family, to citizens of Schengen countries and members of their family as well as to permanent residents of the following countries: Albania, Australia, Northern Macedonia, Bosnia and Herzegovina, United Arab Emirates, United States of America, United Kingdom, Japan, Israel, Canada, Belarus, Lebanon, Montenegro, Bahrain, New Zealand, South Korea, Qatar, China, Kuwait, Ukraine, Rwanda, Russian Federation, Saudi Arabia, Serbia, Singapore and Thailand.
All travelers to Greece, regardless of nationality and way of entering the country, should fill in and submit the electronic PLF (Passenger Locator Form) available at https://travel.gov.gr,
with their contact details in Greece before their arrival in the country. The proof of submission of the PLF, which is automatically sent by e-mail to the passenger, is considered a necessary travel document. A valid PLF form, with a QR code, is considered necessary for the entrance to each entrance gate of the Country.
All travelers to Greece, regardless of nationality and way of entering the country, must meet ONE of the following entry requirements:
*Have completed the vaccination for COVID-19 at least fourteen (14) days before arrival to Greece and present a vaccination certificate in Greek, English, French, German, Italian, Spanish or Russian, issued by a public authority and in accordance with the relevant legislation. The vaccination certificate must include the name of the passenger as indicated on the passport, the type of vaccine administered, the number of doses and the date(s) of vaccination, or
*Have a negative molecular test (PCR) for COVID-19 by taking an oral or nasopharyngeal smear or a negative result of rapid antigen test for COVID-19 a) performed within the last seventy two (72) hours before arrival in Greece for the PCR test and within forty eight (48) hours before arrival in Greece for the rapid test, b) by reference laboratories of the country of origin or transit or public or private laboratories of that country, provided that these private laboratories are certified by the competent national certification authority of the country and c) have a certificate of the above diagnosis, in Greek, English, French, German, Italian, Spanish or Russian language, including the name of the passenger as indicated on the passport, or
*Alternatively, travelers to Greece should have a certificate of illness or positive result of molecular (PCR) or rapid antigen test for COVID-19 valid for two (2) to nine (9) months from the date of illness indicated on it issued thirty (30) days after the first positive test. It should be issued a) by a public authority in accordance with the relevant legislation, b) by reference laboratories of the country of origin or transit or public or private laboratories in that country, provided that such private laboratories
TRAVEL TO ITALY – IMPORTANT INFORMATION
All passengers traveling to Italy are currently needed to
complete before check in a PASSENGER LOCATOR FORM (PLF) via the EUdplf application: https://app.euplf.eu/
-Once connected to the site, you need to:
-Follow the wizard to access the PLF
-Choose “Italy” as the destination country
-Register by creating a personal account with username and password (you only need to do it the first time)
-Fill in and send the PLF following the guided procedure
Once the form has been sent, the passenger will receive the PLF in PDF format and QR-code at the e-mail address indicated during registration, which he will have to show directly from his smart phone (in digital format) at the time of boarding and to anyone appointed to carry out the controls.
From 21 June it is also mandatory to present the: Green Certification Covid19 issued, which shows, alternatively:
a. anti-SARS-CoV-2 vaccination took place, with certification of completion of the prescribed vaccination cycle for at least fourteen days;
b. recovery from COVID-19, with simultaneous cessation of the isolation prescribed following infection with SARS-CoV-2;
c. Carrying out, in the forty-eight (48) hours prior to entry into the national territory, a rapid or molecular antigen test with negative result for the SARS-CoV-2 virus
NB. Children under six (6) years of age are exempted from carrying out the molecular or antigenic test.